vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and MONARCH CASINO & RESORT INC (MCRI). Click either name above to swap in a different company.

MONARCH CASINO & RESORT INC is the larger business by last-quarter revenue ($136.6M vs $83.5M, roughly 1.6× BillionToOne, Inc.). MONARCH CASINO & RESORT INC runs the higher net margin — 20.2% vs 6.8%, a 13.4% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 8.9%).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

The Atlantis Casino Resort Spa is a hotel and casino located in Reno, Nevada, United States. It is owned and operated by Monarch Casino & Resort, Inc. Its three hotel towers have a combined 824 guest rooms and suites. The casino floor spans 64,814 sq ft. Often known simply as "Atlantis," it is one of Reno's most profitable and luxurious properties, competing directly with Peppermill Hotel Casino and Grand Sierra Resort for customers. Nearly $150 million has been spent on upgrading the facility.

BLLN vs MCRI — Head-to-Head

Bigger by revenue
MCRI
MCRI
1.6× larger
MCRI
$136.6M
$83.5M
BLLN
Growing faster (revenue YoY)
BLLN
BLLN
+108.5% gap
BLLN
117.4%
8.9%
MCRI
Higher net margin
MCRI
MCRI
13.4% more per $
MCRI
20.2%
6.8%
BLLN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BLLN
BLLN
MCRI
MCRI
Revenue
$83.5M
$136.6M
Net Profit
$5.7M
$27.6M
Gross Margin
69.9%
Operating Margin
11.5%
25.6%
Net Margin
6.8%
20.2%
Revenue YoY
117.4%
8.9%
Net Profit YoY
138.3%
38.9%
EPS (diluted)
$0.10
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
MCRI
MCRI
Q1 26
$136.6M
Q4 25
$140.0M
Q3 25
$83.5M
$142.8M
Q2 25
$136.9M
Q1 25
$125.4M
Q4 24
$45.1M
$134.5M
Q3 24
$38.4M
$137.9M
Q2 24
$128.1M
Net Profit
BLLN
BLLN
MCRI
MCRI
Q1 26
$27.6M
Q4 25
$22.9M
Q3 25
$5.7M
$31.6M
Q2 25
$27.0M
Q1 25
$19.9M
Q4 24
$-11.5M
$4.2M
Q3 24
$-14.9M
$27.6M
Q2 24
$22.7M
Gross Margin
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
20.8%
Q3 25
69.9%
26.7%
Q2 25
25.5%
Q1 25
20.2%
Q4 24
57.1%
2.9%
Q3 24
52.6%
25.6%
Q2 24
23.0%
Operating Margin
BLLN
BLLN
MCRI
MCRI
Q1 26
25.6%
Q4 25
21.3%
Q3 25
11.5%
27.1%
Q2 25
25.8%
Q1 25
20.4%
Q4 24
17.0%
3.1%
Q3 24
-32.9%
25.5%
Q2 24
22.9%
Net Margin
BLLN
BLLN
MCRI
MCRI
Q1 26
20.2%
Q4 25
16.4%
Q3 25
6.8%
22.1%
Q2 25
19.7%
Q1 25
15.8%
Q4 24
-25.5%
3.1%
Q3 24
-38.8%
20.0%
Q2 24
17.7%
EPS (diluted)
BLLN
BLLN
MCRI
MCRI
Q1 26
$1.52
Q4 25
$1.25
Q3 25
$0.10
$1.69
Q2 25
$1.44
Q1 25
$1.05
Q4 24
$-1.13
$0.25
Q3 24
$-1.47
$1.47
Q2 24
$1.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
MCRI
MCRI
Cash + ST InvestmentsLiquidity on hand
$195.2M
$120.1M
Total DebtLower is stronger
$55.0M
Stockholders' EquityBook value
$-239.5M
$549.8M
Total Assets
$327.5M
$725.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
MCRI
MCRI
Q1 26
$120.1M
Q4 25
Q3 25
$195.2M
Q2 25
Q1 25
Q4 24
$191.5M
Q3 24
Q2 24
Total Debt
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
Q3 25
$55.0M
Q2 25
Q1 25
Q4 24
$51.5M
Q3 24
Q2 24
Stockholders' Equity
BLLN
BLLN
MCRI
MCRI
Q1 26
$549.8M
Q4 25
$537.7M
Q3 25
$-239.5M
$558.4M
Q2 25
$539.2M
Q1 25
$535.6M
Q4 24
$-251.7M
$517.7M
Q3 24
$-242.9M
$513.3M
Q2 24
$498.4M
Total Assets
BLLN
BLLN
MCRI
MCRI
Q1 26
$725.2M
Q4 25
$712.8M
Q3 25
$327.5M
$725.4M
Q2 25
$705.8M
Q1 25
$712.1M
Q4 24
$302.1M
$691.6M
Q3 24
$671.1M
Q2 24
$672.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
MCRI
MCRI
Operating Cash FlowLast quarter
$13.8M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
7.7%
Capex IntensityCapex / Revenue
8.8%
Cash ConversionOCF / Net Profit
2.42×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
$38.1M
Q3 25
$13.8M
$56.0M
Q2 25
$34.1M
Q1 25
$36.5M
Q4 24
$37.8M
Q3 24
$40.3M
Q2 24
$24.3M
Free Cash Flow
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
$32.2M
Q3 25
$6.5M
$53.5M
Q2 25
$26.0M
Q1 25
$16.6M
Q4 24
$26.2M
Q3 24
$35.4M
Q2 24
$11.0M
FCF Margin
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
23.0%
Q3 25
7.7%
37.5%
Q2 25
19.0%
Q1 25
13.3%
Q4 24
19.5%
Q3 24
25.7%
Q2 24
8.5%
Capex Intensity
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
4.2%
Q3 25
8.8%
1.7%
Q2 25
5.9%
Q1 25
15.8%
Q4 24
8.6%
Q3 24
3.6%
Q2 24
10.4%
Cash Conversion
BLLN
BLLN
MCRI
MCRI
Q1 26
Q4 25
1.66×
Q3 25
2.42×
1.77×
Q2 25
1.26×
Q1 25
1.84×
Q4 24
8.98×
Q3 24
1.46×
Q2 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

MCRI
MCRI

Casino$79.7M58%
Food and beverage$31.7M23%
Hotel$19.0M14%
Other$6.1M5%

Related Comparisons